Annual D&A
$4.29 M
+$3.04 M+242.46%
31 December 2023
Summary:
Tonix Pharmaceuticals Holding annual depreciation & amortization is currently $4.29 million, with the most recent change of +$3.04 million (+242.46%) on 31 December 2023. During the last 3 years, it has risen by +$4.26 million (+15792.59%). TNXP annual D&A is now at all-time high.TNXP Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$510.00 K
-$695.00 K-57.68%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding quarterly depreciation & amortization is currently $510.00 thousand, with the most recent change of -$695.00 thousand (-57.68%) on 30 September 2024. Over the past year, it has dropped by -$706.00 thousand (-58.06%). TNXP quarterly D&A is now -59.56% below its all-time high of $1.26 million, reached on 31 December 2023.TNXP Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$4.19 M
-$706.00 K-14.43%
30 September 2024
Summary:
Tonix Pharmaceuticals Holding TTM depreciation & amortization is currently $4.19 million, with the most recent change of -$706.00 thousand (-14.43%) on 30 September 2024. Over the past year, it has increased by +$320.00 thousand (+8.28%). TNXP TTM D&A is now -14.43% below its all-time high of $4.89 million, reached on 30 June 2024.TNXP TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNXP Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +242.5% | -58.1% | +8.3% |
| 3 y3 years | +10000.0% | +5000.0% | +10000.0% |
| 5 y5 years | +7846.3% | +10000.0% | +10000.0% |
TNXP Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | -59.6% | +5000.0% | -14.4% | >+9999.0% |
| 5 y | 5 years | at high | >+9999.0% | -59.6% | >+9999.0% | -14.4% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -59.6% | >+9999.0% | -14.4% | >+9999.0% |
Tonix Pharmaceuticals Holding Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $510.00 K(-57.7%) | $4.19 M(-14.4%) |
| June 2024 | - | $1.21 M(-0.4%) | $4.89 M(+6.2%) |
| Mar 2024 | - | $1.21 M(-4.0%) | $4.61 M(+7.4%) |
| Dec 2023 | $4.29 M(+242.5%) | $1.26 M(+3.7%) | $4.29 M(+11.0%) |
| Sept 2023 | - | $1.22 M(+32.0%) | $3.87 M(+33.2%) |
| June 2023 | - | $921.00 K(+3.1%) | $2.90 M(+39.3%) |
| Mar 2023 | - | $893.00 K(+6.8%) | $2.08 M(+66.2%) |
| Dec 2022 | $1.25 M(+2406.0%) | $836.00 K(+231.7%) | $1.25 M(+182.2%) |
| Sept 2022 | - | $252.00 K(+147.1%) | $444.00 K(+119.8%) |
| June 2022 | - | $102.00 K(+61.9%) | $202.00 K(+88.8%) |
| Mar 2022 | - | $63.00 K(+133.3%) | $107.00 K(+114.0%) |
| Dec 2021 | $50.00 K(+85.2%) | $27.00 K(+170.0%) | $50.00 K(+66.7%) |
| Sept 2021 | - | $10.00 K(+42.9%) | $30.00 K(+7.1%) |
| June 2021 | - | $7000.00(+16.7%) | $28.00 K(+3.7%) |
| Mar 2021 | - | $6000.00(-14.3%) | $27.00 K(0.0%) |
| Dec 2020 | $27.00 K(+3.8%) | $7000.00(-12.5%) | $27.00 K(+8.0%) |
| Sept 2020 | - | $8000.00(+33.3%) | $25.00 K(+13.6%) |
| June 2020 | - | $6000.00(0.0%) | $22.00 K(-4.3%) |
| Mar 2020 | - | $6000.00(+20.0%) | $23.00 K(-11.5%) |
| Dec 2019 | $26.00 K(-51.9%) | $5000.00(0.0%) | $26.00 K(-18.8%) |
| Sept 2019 | - | $5000.00(-28.6%) | $32.00 K(-20.0%) |
| June 2019 | - | $7000.00(-22.2%) | $40.00 K(-16.7%) |
| Mar 2019 | - | $9000.00(-18.2%) | $48.00 K(-11.1%) |
| Dec 2018 | $54.00 K(-22.9%) | $11.00 K(-15.4%) | $54.00 K(-14.3%) |
| Sept 2018 | - | $13.00 K(-13.3%) | $63.00 K(-4.5%) |
| June 2018 | - | $15.00 K(0.0%) | $66.00 K(+8.2%) |
| Mar 2018 | - | $15.00 K(-25.0%) | $61.00 K(-12.9%) |
| Dec 2017 | $70.00 K | $20.00 K(+25.0%) | $70.00 K(-54.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | $16.00 K(+60.0%) | $155.00 K(-10.4%) |
| June 2017 | - | $10.00 K(-58.3%) | $173.00 K(0.0%) |
| Mar 2017 | - | $24.00 K(-77.1%) | $173.00 K(-16.0%) |
| Dec 2016 | $206.00 K(+28.0%) | $105.00 K(+208.8%) | $206.00 K(+19.8%) |
| Sept 2016 | - | $34.00 K(+240.0%) | $172.00 K(-6.0%) |
| June 2016 | - | $10.00 K(-82.5%) | $183.00 K(-6.6%) |
| Mar 2016 | - | $57.00 K(-19.7%) | $196.00 K(+21.7%) |
| Dec 2015 | $161.00 K(+347.2%) | $71.00 K(+57.8%) | $161.00 K(+45.0%) |
| Sept 2015 | - | $45.00 K(+95.7%) | $111.00 K(+54.2%) |
| June 2015 | - | $23.00 K(+4.5%) | $72.00 K(+33.3%) |
| Mar 2015 | - | $22.00 K(+4.8%) | $54.00 K(+50.0%) |
| Dec 2014 | $36.00 K(+111.8%) | $21.00 K(+250.0%) | $36.00 K(+80.0%) |
| Sept 2014 | - | $6000.00(+20.0%) | $20.00 K(+11.1%) |
| June 2014 | - | $5000.00(+25.0%) | $18.00 K(+5.9%) |
| Mar 2014 | - | $4000.00(-20.0%) | $17.00 K(0.0%) |
| Dec 2013 | $17.00 K(+21.4%) | $5000.00(+25.0%) | $17.00 K(+7.6%) |
| Sept 2013 | - | $4000.00(0.0%) | $15.80 K(-0.6%) |
| June 2013 | - | $4000.00(0.0%) | $15.90 K(+1.3%) |
| Mar 2013 | - | $4000.00(+5.3%) | $15.70 K(+11.3%) |
| Dec 2012 | $14.00 K(+50.5%) | $3800.00(-7.3%) | $14.10 K(+11.0%) |
| Sept 2012 | - | $4100.00(+7.9%) | $12.70 K(+15.5%) |
| June 2012 | - | $3800.00(+58.3%) | $11.00 K(+14.6%) |
| Mar 2012 | - | $2400.00(0.0%) | $9600.00(+2.1%) |
| Dec 2011 | $9300.00(+138.5%) | $2400.00(0.0%) | $9400.00(+34.3%) |
| Sept 2011 | - | $2400.00(0.0%) | $7000.00(+52.2%) |
| June 2011 | - | $2400.00(+9.1%) | $4600.00(+109.1%) |
| Mar 2011 | - | $2200.00 | $2200.00 |
| Dec 2010 | $3900.00 | - | - |
FAQ
- What is Tonix Pharmaceuticals Holding annual depreciation & amortization?
- What is the all time high annual D&A for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding annual D&A year-on-year change?
- What is Tonix Pharmaceuticals Holding quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding quarterly D&A year-on-year change?
- What is Tonix Pharmaceuticals Holding TTM depreciation & amortization?
- What is the all time high TTM D&A for Tonix Pharmaceuticals Holding?
- What is Tonix Pharmaceuticals Holding TTM D&A year-on-year change?
What is Tonix Pharmaceuticals Holding annual depreciation & amortization?
The current annual D&A of TNXP is $4.29 M
What is the all time high annual D&A for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high annual depreciation & amortization is $4.29 M
What is Tonix Pharmaceuticals Holding annual D&A year-on-year change?
Over the past year, TNXP annual depreciation & amortization has changed by +$3.04 M (+242.46%)
What is Tonix Pharmaceuticals Holding quarterly depreciation & amortization?
The current quarterly D&A of TNXP is $510.00 K
What is the all time high quarterly D&A for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high quarterly depreciation & amortization is $1.26 M
What is Tonix Pharmaceuticals Holding quarterly D&A year-on-year change?
Over the past year, TNXP quarterly depreciation & amortization has changed by -$706.00 K (-58.06%)
What is Tonix Pharmaceuticals Holding TTM depreciation & amortization?
The current TTM D&A of TNXP is $4.19 M
What is the all time high TTM D&A for Tonix Pharmaceuticals Holding?
Tonix Pharmaceuticals Holding all-time high TTM depreciation & amortization is $4.89 M
What is Tonix Pharmaceuticals Holding TTM D&A year-on-year change?
Over the past year, TNXP TTM depreciation & amortization has changed by +$320.00 K (+8.28%)